Search results

Oxford Nanopore Technologies Reckitt Benckiser We advised Reckitt Benckiser Group on the sale of its Infant Formula and Child Nutrition Business in China to Primavera Capital Group, a China-based private equity company, for over $2 billion. Meta Platforms Inc We advised Meta in relation to the competition law aspects of its acquisition of Kustomer, an omnichannel customer service CRM platform. INEOS INEOS case study Arm Holdings Plc Synthomer Plc M&A deals under the microscope In recent years, dealmakers have grappled with an increasingly interventionist and unpredictable regulatory environment for M&A. However, there are signs that the momentum of interventionism is beginning to change with calls from politicians to make m... Private capital's year of building momentum: Is the stage set for 2025? 2024 remained a challenging year for private equity fundraisings, investments and exits. Assets purchased in the era of cheap leverage and high multiples remained locked, with many auction processes failing to take off or being interrupted, while macro-ec... M&A health-check: will favourable conditions and regulatory easing drive M&A growth in 2025? 2024 was a mixed year for dealmaking, with deal values, if not volumes, increasing compared to 2023. Whilst private capital saw a moderate increase in activity, 2024 has been notable for the significant uptick in larger corporate-to-corporate activity in ... Private equity: the evolution of an industry Since the advent of the modern private equity industry in the early 1980s, private equity houses have traditionally adopted the classic model of a buyout fund, raising capital from a club of large institutional investors to fund acquisitions and drive gro...